Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas oleh D. Bradley Welling, Katharine A. Collier, Sarah S. Burns, Janet L. Oblinger, Edina Shu, Beth A. Miles‐Markley, Craig C. Hofmeister, Mina S. Makary, H. Wayne Slone, Jaishri O. Blakeley, S. Alireza Mansouri, Brian A. Neff, Robert K. Jackler, Amir Mortazavi, Long‐Sheng Chang